68 results on '"Li, Chin-Yang"'
Search Results
2. Risk factors for leukemic transformation in patients with primary myelofibrosis
3. Pruritus in polycythemia vera is associated with a lower risk of arterial thrombosis
4. 20+ yr without leukemic or fibrotic transformation in essential thrombocythemia or polycythemia vera: predictors at diagnosis
5. Hematological manifestations of copper deficiency: a retrospective review
6. Cytogenetic studies at diagnosis in polycythemia vera: clinical and JAK2V617F allele burden correlates
7. Leucocytosis in polycythaemia vera predicts both inferior survival and leukaemic transformation
8. Validation and comparison of contemporary prognostic models in primary myelofibrosis
9. Clinical correlates ofJAK2V617F allele burden in essential thrombocythemia
10. C-terminal nucleophosmin mutations are uncommon in chronic myeloid disorders
11. Prognosis in transplant-eligible patients with agnogenic myeloid metaplasia
12. The clinical phenotype of wild-type, heterozygous, and homozygous JAK2V617F in polycythemia vera
13. Presence of unfavorable cytogenetic abnormalities is the strongest predictor of poor survival in secondary myelofibrosis
14. Respective clustering of unfavorable and favorable cytogenetic clones in myelofibrosis with myeloid metaplasia with homozygosity for JAK2V617F and response to erythropoietin therapy
15. The JAK2V617F tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates
16. Prognostic diversity among cytogenetic abnormalities in myelofibrosis with myeloid metaplasia
17. Concomitant neutrophil JAK2V617F mutation screening and PRV-1 expression analysis in myeloproliferative disorders and secondary polycythaemia
18. Human leucocyte antigen class I and killer immunoglobulin‐like receptor expression patterns in T‐cell large granular lymphocyte leukaemia
19. Clinical importance of bone marrow monocytic nodules in patients with myelodysplasia: Retrospective analysis of 21 cases
20. Differential expression of CD2 on neoplastic mast cells in patients with systemic mast cell disease with and without an associated clonal haematological disorder
21. Thalidomide treatment in myelofibrosis with myeloid metaplasia
22. Simultaneous measurement of serum thrombopoietin and expression of megakaryocyte c-Mpl with clinical and laboratory correlates for myelofibrosis with myeloid metaplasia
23. A phase II trial of pirfenidone (5‐methyl‐1‐phenyl‐2‐[1H]‐pyridone), a novel anti‐fibrosing agent, in myelofibrosis with myeloid metaplasia
24. Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia
25. Malignant lymphoma in southern Taiwan according to the revised European–American classification of lymphoid neoplasms
26. Megakaryocyte c-Mpl expression inchronic myeloproliferative disorders and the myelodysplastic syndrome: immunoperoxidase staining patterns and clinical correlates
27. Bone marrow effects of anagrelide therapy in patients with myelofibrosis with myeloid metaplasia
28. Whipple's arthritis: Direct detection ofTropheryma whippelii in synovial fluid and tissue
29. Chronic lymphocytic leukaemia with symptomatic diffuse central nervous system infiltration responding to therapy with systemic fludarabine
30. Epstein-Barr virus infection in Richter's transformation
31. Multiple lymphoid nodules in bone marrow have the same clonality as underlying myelodysplastic syndrome recognized with fluorescent in situ hybridization technique
32. 2‐Chlorodeoxyadenosine treatment after splenectomy in patients who have myelofibrosis with myeloid metaplasia
33. Bone marrow granulomas associated with chronic natural killer cell lymphocytosis
34. A cohort study of cancer among benzene-exposed workers in China: Overall results
35. Primary systemic amyloidosis presenting as giant cell arteritis and polymyalgia rheumatica
36. Cutaneous histiocytic malignancy. Immunohistochemical re-examination of cases previously diagnosed as cutaneous "histiocytic lymphoma" and "malignant histiocytosis"
37. Is persistent polyclonal b lymphocytosis caused by epstein‐barr virus? A study with polymerase chain reaction and in situ hybridization
38. Leukemic manifestation in a case of alpha‐chain disease with multiple polypoid intestinal lymphocytic lymphoma
39. Value of immunohistochemistry in the diagnosis of leukemia cutis: study of 54 cases using paraffin-section markers
40. Unusual presentation of extranodal peripheral T-cell lymphomas with multiple paraneoplastic features
41. Subungual Leukemia Cutis
42. Immunoperoxidase staining of bone marrow sections
43. Acute lymphoblastic leukemia in children: Immunologic, cytochemical, morphologic, and cytogenetic studies in relation to pretreatment risk factors
44. Improved immunohistochemical detection of prostatic acid phosphatase by a monoclonal antibody
45. Acute lymphocytic leukemia: Correlation of clinical features with immunocytochemical classification
46. Diagnosis of B-cell non-hodgkin's lymphoma of the central nervous system by immunocytochemical analysis of cerebrospinal fluid lymphocytes
47. Significance of systemic mast cell disease with associated hematologic disorders
48. Immunoelectron microscopic demonstration of prostatic acid phosphatase in human hyperplastic prostate
49. Hepatic involvement in hairy cell leukemia
50. Systemic mast cell disease: A clinical and hematopathologic study of 26 cases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.